The latest treatment advances of severe acquired aplastic anemia / 中华实用儿科临床杂志
Chinese Journal of Applied Clinical Pediatrics
; (24): 236-238, 2015.
Article
in Chinese
| WPRIM (Western Pacific)
| ID: wpr-466685
Responsible library:
WPRO
ABSTRACT
Acquired aplastic anemia is a refractory blood disease for children,and severe acquired aplastic anemia can be a great threaten for life.China is a high incidengce area,children at a period during which this disease can mostly occur.In China,except some congenital aplastic anemia,most children who have this diease is acquired aplastic anemia.In 2009,the Britain society of hematology recommended Guidelines for the diagnosis and management of aplastic anaemia,which represented the latest diagnosis and treatment principle and mainstream view of the clinical methodology about aplastic anemia.They make it clear that the main treatment for the disease are allogeneic hematopoietic stem cell transplantation(allo-HSCT) and immunosuppressive therapy(IST).This article collects the documents in recent 5 years,and provides a overview about the latest advance of the allo-HSCT and IST in the word.
Full text:
Available
Database:
WPRIM (Western Pacific)
Type of study:
Practice guideline
Language:
Chinese
Journal:
Chinese Journal of Applied Clinical Pediatrics
Year:
2015
Document type:
Article